Scientific Advisory Board

Dr. Pitt is a Professor Emeritus in Medicine at the University of Michigan School of Medicine, US. Pitt assumed directorship of the division of Cardiology at the University of Michigan School of Medicine in 1977. Among his achievements, he has been awarded the James B Herrick award from the American Heart Association as well as life-time achievement awards from the Heart Failure Society of America and the European Heart Failure Society. He has served on the editorial boards of several cardiovascular journals and has published over 750 articles, chapters and books. Co-chairman, CVCT Global Forum.

Dr. Benza is currently Section Chief of Cardiology at the Macon & Joan Brock Virginia Health Sciences Eastern Virginia Medical School at Old Dominion University and the George and Linda Kaufman Academic Chair of Cardiology at Sentara Health in Norfolk, Virginia, Principal Investigator of the Phase II study of CS1, and member of Cereno’s Scientific Advisory Board. He has extensive clinical trial experience with involvement in just over 60 different clinical trials. Dr. Benza has also been involved in around 325 publications and written 6 books of which 3 are focused on pulmonary hypertension.

Dr. Deepak Bhatt was Professor of Medicine at Harvard Medical School between 2012–2022. He has been listed in Best Doctors in America from 2005 to 2020. Dr. Bhatt has authored or co-authored over 1900 publications and has been listed by the Web of Science Group as a Highly Cited Researcher from 2014 to 2022. He is the Editor of Cardiovascular Intervention: A Companion to Braunwald’s Heart Disease and of Opie's Cardiovascular Drugs: A Companion to Braunwald's Heart Disease.

Born 1953. Dr. Gunnar Olsson is an MD, PhD in Medical Sciences at the Karolinska Institute. Dr. Gunnar Olsson is an MD, PhD in Medical Sciences at the Karolinska Institute. He was previously Adjunct Professor at the Karolinska Institute and has extensive experience from leading R&D positions in the pharmaceutical industry. He has over 20 years of experience in different Global R&D management positions at AstraZeneca and contributed to more than a dozen successful global product registrations for medicines in cardiovascular, vascular and gastrointestinal indications. Dr. Gunnar Olsson has been on the board of ESC, that awarded him the ESC President Award in recognition of his outstanding lifetime achievements, in 2023. He was a board member in Cereno Scientific between 2016-2018 and has been a member of the Scientific Advisory Board since this was established in 2019. Dr. Gunnar Olsson has been a senior advisor to the executive management team since 2018. Olsson is a Board member of IRLAB Therapeutics AB and Amplifier Tx AB. He is Vice Chair for the Swedish Heart Lung Foundation and Bundy Academy, Lund University.

Considered independent of the company, its management and major shareholders.

Shareholding: 5,000 Class B shares and 600,000 warrants.

Dr. Williams is a Professor of Medicine at Harvard Medical School since 1981 and was the founder and Director of its Scholars in Clinical Science Program until 2008. A lifelong interest of Williams has been to understand the mechanisms by which aldosterone participates in cardiovascular diseases. He has published more than 600 original articles, reviews, chapters and books, including co-editing his seminal textbook “Clinical and Translational Science.”

Dr. Zannad is a Professor Emeritus of Therapeutics and Cardiology at Université de Lorraine, France. Zannad is involved in a number of major cardiovascular clinical trials, as a Principal Investigator and/or as a chair or member of several Steering Committees, Critical Event Committees and Data Safety and Monitoring Boards. Founder & chairman, CVCT Global Forum.